Cargando…
METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas
A considerable amount of literature has demonstrated that eukaryotic translation elongation factor 1A (eEF1A) is closely related to tumors. As a newly identified lysine specific methyltransferase targeting eEF1A at Lys-165, too little attention has been paid to the function of METTL21B. To determine...
Autores principales: | Shu, Xin, Li, Xinquan, Xiang, Xiaochen, Wang, Qiang, Wu, Qingming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436898/ https://www.ncbi.nlm.nih.gov/pubmed/34446611 http://dx.doi.org/10.18632/aging.203454 |
Ejemplares similares
-
METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
por: Jiang, Zhipeng, et al.
Publicado: (2021) -
S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma
por: Zhang, Yu, et al.
Publicado: (2021) -
Prognostic role of METTL1 in glioma
por: Li, Lun, et al.
Publicado: (2021) -
OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma
por: An, Yang, et al.
Publicado: (2020) -
CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma
por: Wang, Dengfeng, et al.
Publicado: (2022)